Seguir
Hassan Fathallah-Shaykh
Hassan Fathallah-Shaykh
Dirección de correo verificada de uab.edu
Título
Citado por
Citado por
Año
Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge
S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ...
arXiv preprint arXiv:1811.02629, 2018
17852018
The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification
U Baid, S Ghodasara, S Mohan, M Bilello, E Calabrese, E Colak, ...
arXiv preprint arXiv:2107.02314, 2021
5022021
Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.
H Fathallah-Shaykh, S Wolf, E Wong, JB Posner, HM Furneaux
Proceedings of the National Academy of Sciences 88 (8), 3451-3454, 1991
1751991
Gene transfer of IFN-γ into established brain tumors represses growth by antiangiogenesis
HM Fathallah-Shaykh, LJ Zhao, AI Kafrouni, GM Smith, J Forman
The Journal of Immunology 164 (1), 217-222, 2000
1172000
Identifying the best machine learning algorithms for brain tumor segmentation
S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ...
progression assessment, and overall survival prediction in the BRATS …, 2018
1152018
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
X Han, R Li, W Zhang, X Yang, CG Wheeler, GK Friedman, P Province, ...
Journal of Neuro-oncology 118, 61-72, 2014
1062014
Rationally designed pharmacogenomic treatment using concurrent capecitabine and radiotherapy for glioblastoma; gene expression profiles associated with outcome
JM Grunda, J Fiveash, CA Palmer, A Cantor, HM Fathallah-Shaykh, ...
Clinical cancer research 16 (10), 2890-2898, 2010
822010
Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
PY Wen, A Omuro, MS Ahluwalia, HM Fathallah-Shaykh, N Mohile, ...
Neuro-oncology 17 (9), 1275-1283, 2015
762015
A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma
LB Nabors, JB Fiveash, JM Markert, MS Kekan, GY Gillespie, Z Huang, ...
Archives of neurology 67 (3), 313-319, 2010
752010
A multilayer grow-or-go model for GBM: effects of invasive cells and anti-angiogenesis on growth
O Saut, JB Lagaert, T Colin, HM Fathallah-Shaykh
Bulletin of mathematical biology 76, 2306-2333, 2014
742014
The role of Src family kinases in growth and migration of glioma stem cells
X Han, W Zhang, X Yang, CG Wheeler, CP Langford, L Wu, N Filippova, ...
International journal of oncology 45 (1), 302-310, 2014
702014
The federated tumor segmentation (fets) challenge
S Pati, U Baid, M Zenk, B Edwards, M Sheller, GA Reina, P Foley, ...
arXiv preprint arXiv:2105.05874, 2021
662021
Optic neuropathy in patients with glioblastoma receiving bevacizumab
JH Sherman, DG Aregawi, A Lai, HM Fathallah-Shaykh, PJ Bierman, ...
Neurology 73 (22), 1924-1926, 2009
572009
Gene expression analysis in radiotherapy patients and C57BL/6 mice as a measure of exposure to ionizing radiation
AN Filiano, HM Fathallah-Shaykh, J Fiveash, J Gage, A Cantor, ...
Radiation research 176 (1), 49-61, 2011
552011
Inception modules enhance brain tumor segmentation
DE Cahall, G Rasool, NC Bouaynaya, HM Fathallah-Shaykh
Frontiers in computational neuroscience 13, 44, 2019
542019
Microarrays: applications and pitfalls
HM Fathallah-Shaykh
Archives of neurology 62 (11), 1669-1672, 2005
522005
Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme
CE Griguer, AB Cantor, HM Fathallah-Shaykh, GY Gillespie, AS Gordon, ...
PloS one 8 (4), e61035, 2013
482013
The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification. arXiv 2021
U Baid, S Ghodasara, S Mohan, M Bilello, E Calabrese, E Colak, ...
arXiv preprint arXiv:2107.02314, 2021
472021
Priming in the brain, an immunologically privileged organ, elicits anti‐tumor immunity
HM Fathallah‐Shaykh, W Gao, M Cho, MA Herrera
International journal of cancer 75 (2), 266-276, 1998
471998
Genomic expression discovery predicts pathways and opposing functions behind phenotypes
HM Fathallah-Shaykh, B He, LJ Zhao, HH Engelhard, L Cerullo, T Lichtor, ...
Journal of Biological Chemistry 278 (26), 23830-23833, 2003
442003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20